Dimensional Fund Advisors
FULC icon

Dimensional Fund Advisors’s Fulcrum Therapeutics FULC Stock Holding History

Dimensional Fund Advisors’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.66M Buy
1,130,281
+79,157
+8% +$734K ﹤0.01% 2305
2025
Q4 		$11.9M Sell
1,051,124
-248,184
-19% -$2.53M ﹤0.01% 2225
2025
Q3 		$12M Sell
1,299,308
-73,329
-5% -$531K ﹤0.01% 2240
2025
Q2 		$9.44M Sell
1,372,637
-34,412
-2% -$184K ﹤0.01% 2303
2025
Q1 		$4.05M Sell
1,407,049
-11,641
-0.8% -$42.8K ﹤0.01% 2556
2024
Q4 		$6.67M Sell
1,418,690
-4,805
-0.3% -$17.7K ﹤0.01% 2454
2024
Q3 		$5.08M Sell
1,423,495
-57,431
-4% -$426K ﹤0.01% 2515
2024
Q2 		$9.18M Buy
1,480,926
+176,114
+13% +$1.33M ﹤0.01% 2302
2024
Q1 		$12.3M Buy
1,304,812
+329,533
+34% +$2.94M ﹤0.01% 2215
2023
Q4 		$6.58M Buy
975,279
+413,281
+74% +$1.83M ﹤0.01% 2478
2023
Q3 		$2.5M Buy
561,998
+86,663
+18% +$379K ﹤0.01% 2712
2023
Q2 		$1.57M Sell
475,335
-279,551
-37% -$821K ﹤0.01% 2841
2023
Q1 		$2.15M Buy
754,886
+368,054
+95% +$3.3M ﹤0.01% 2730
2022
Q4 		$2.82K Buy
386,832
+152,752
+65% +$996K ﹤0.01% 2624
2022
Q3 		$1.89M Sell
234,080
-128,024
-35% -$917K ﹤0.01% 2723
2022
Q2 		$1.77M Buy
362,104
+79,311
+28% +$775K ﹤0.01% 2776
2022
Q1 		$6.69M Buy
282,793
+95,272
+51% +$1.35M ﹤0.01% 2448
2021
Q4 		$3.32M Buy
187,521
+136,773
+270% +$2.71M ﹤0.01% 2699
2021
Q3 		$1.43M Sell
50,748
-24,835
-33% -$471K ﹤0.01% 2947
2021
Q2 		$792K Buy
75,583
+25,768
+52% +$261K ﹤0.01% 3080
2021
Q1 		$587K Buy
+49,815
New +$616K ﹤0.01% 3114

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Dimensional Fund Advisors's FULC Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Fulcrum Therapeutics (FULC) stake by 7.5% in Q1 2026, buying an estimated $734K and bringing the position to 1,130,281 shares worth $8.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

Dimensional Fund Advisors first reported a position in FULC in Q1 2021 and has held it in 21 quarters since. The position peaked at $12.3M in Q1 2024. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Dimensional Fund Advisors held 1,130,281 shares of Fulcrum Therapeutics worth $8.66M as of Q1 2026.
  • Dimensional Fund Advisors bought 79,157 Fulcrum Therapeutics shares in Q1 2026, an estimated $734K.
  • Fulcrum Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2305 holding.
  • Dimensional Fund Advisors first reported a position in Fulcrum Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Dimensional Fund Advisors's Fulcrum Therapeutics position peaked at $12.3M in Q1 2024.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.